Abstract
Antibodies against the influenza virus hemagglutinin stalk afford broad protection against antigenically drifted viruses. In this issue of Cell Reports Medicine, Yegorov et al.(1) identify that current vaccine formulations induce neutralizing stalk antibodies in children-a highly vulnerable population.